Newswise — December 12, 2014 –Wolters Kluwer Health is pleased to announce that, Retinal Cases & Brief Reports, a publication dedicated to publishing peer-reviewed case reports and brief reports in the diagnosis and treatment of retinal and vitreous diseases, has been accepted for indexing by MEDLINE/PubMed and Scopus. All articles back to Volume 1 Issue 1 now appear in PubMed and going forward all articles will be indexed immediately upon publication.

PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. MEDLINE includes citations from over 5,600 scholarly journals published around the world. Inclusion of Retinal Cases & Brief Reports in MEDLINE/PubMed will provide international visibility and recognition for the journal’s authors, and confirms the importance of the growing field of ophthalmology.

Retinal Cases & Brief Reports, first published in 2007, publishes instructive and challenging cases that take the reader from the initial case presentation through the work-up, differential diagnosis, treatment, and follow-up. A world class editorial board is committed to providing the highest level of discussion and expertise in the evaluation of these interesting and timely cases and brief reports.

The editorial team for Retinal Cases & Brief Reports is led by Editor-in-Chief Dr. Alexander J. Brucker who is also the Editor of the internationally acclaimed subspecialty journal, RETINA, The Journal of Retinal and Vitreous Diseases. To learn more about author information and submissions visit http://www.editorialmanager.com/retinalcases/.

###

About Wolters Kluwer Health Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth.